Docaravimab
Based on 1 Customer Validation
Docaravimab is an antibody, targeting ERA (Evelyn-Rockitniki-Abelseth) glycoprotein ectodomain epitope G-III. Docaravimab can be used in research of Rabies.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 99.27%
- No. CAS: 2247196-23-0
- Peso molecular:146.48 kDa
-
Almacenamiento:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Isotype
Mouse IgG2b kappa
Recommend Isotype Controls
Species Reactivity
Rabies lyssavirus
IC50 & Target
ERA
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
IgG2b-kappa
Aplicación
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized human Rabies virus Glycoprotein G His Tag can bind Docaravimab. The EC50 for this effect is 12.13 ng/mL.
Chemical Information
-
No. CAS 2247196-23-0
-
Appearance Liquid
-
Peso molecular 146.48 kDa
-
Color Colorless to light yellow
-
SMILES
[Docaravimab]
-
Synonyms
62-71-3
-
Envío
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
Ficha de datos (257 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)